Alphatec Holdings (ATEC) Receives a Buy from Needham

Needham analyst David Saxon reiterated a Buy rating on Alphatec Holdings (ATECResearch Report) today and set a price target of $15.00. The company’s shares closed last Thursday at $10.79.

According to TipRanks.com, Saxon ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.7% and a 19.3% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Globus Medical, and Staar Surgical.

Currently, the analyst consensus on Alphatec Holdings is a Strong Buy with an average price target of $17.33, implying a 57.4% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $20.00 price target.

See the top stocks recommended by analysts >>

Alphatec Holdings’ market cap is currently $1.08B and has a P/E ratio of -7.26.

Based on the recent corporate insider activity of 71 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ATEC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Read More on ATEC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More